Founded in 2002, a leading enterprise analytics firm introduced an innovative Unlimited GenAI platform in September 2024, designed for scalability and advanced analytics applications. This platform incorporates features like "Chat with Your Data" and AI-driven dashboard creation, facilitating natural language interaction and simplifying analytics tasks for a wide range of users. Key attributes include seamless integration with APIs, extensive data management, and enterprise-grade security features. Designed for large-scale data environments, its flexible cloud architecture offers unparalleled adaptability and robust analytical capabilities. The platform's conversational AI assistant harnesses advanced language models to deliver precise analytics insights, while its interactive dashboards capitalize on GenAI-assisted authoring for compelling visual representations. Additionally, it supports seamless data preparation and analysis, customizable model integrations, and API-driven integration, allowing for extensive customization and white-labeling capabilities. The integration of leading Large Language Models further empowers enterprises to tailor AI insights to specific needs. Maintained by a specialized team of fewer than 10, the business combines development, product management, and customer support to ensure its platform meets evolving market demands. Despite the platform's recent release, it has shown significant revenue potential, earning $738K in the trailing 12 months through professional and support services. Positioned for growth, the firm identifies opportunities in SaaS application integration, marketing expansion, affiliate partnerships, and geographical diversification. Seeking a strategic acquirer to scale its sales and marketing efforts, the company offers a valuable opportunity to leverage extensive R&D investment and a breakthrough GenAI platform within the rapidly expanding analytics market. This acquisition promises immediate market penetration and substantial long-term potential for recurring revenue.